228
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Repetitive drug-induced liver injury with kedaling tablets

Pages 853-854 | Received 25 Dec 2020, Accepted 21 Jan 2021, Published online: 12 Feb 2021
 

Acknowledgment

We thank Shijian Wang for linguistic assistance during the preparation of this manuscript.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Figure 1. Evolution of AST, ALT, GGT and ALP levels with kedaling tablets exposure and discontinuation. Differences in AST and ALT are statistically different from the reference range at p < .01.

Figure 1. Evolution of AST, ALT, GGT and ALP levels with kedaling tablets exposure and discontinuation. Differences in AST and ALT are statistically different from the reference range at p < .01.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.